4.8 Article

Tostadin, a novel antibacterial peptide from an antagonistic microorganism Brevibacillus brevis XDH

Journal

BIORESOURCE TECHNOLOGY
Volume 111, Issue -, Pages 504-506

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biortech.2012.02.051

Keywords

Brevibacillus brevis; Antibacterial peptide; Purification; Characterization

Ask authors/readers for more resources

A novel small antibacterial peptide was obtained from the liquid culture of Brevibacillus brevis XDH, which is a broad-spectrum antagonistic bacterium isolated from the soil of Mountain Tai, China. This peptide was purified from the fermentation medium of strain XDH via ammonium sulfate precipitation, cation exchange chromatography, and reversed-phase high-performance liquid chromatography (HPLC), successively. The structure of the active linear peptide was elucidated using mass spectra (MS) and nuclear magnetic resonance (NMR) analyses that consisted of nine amino acids. This peptide was easily soluble in water, thermally stable and strongly inhibited the growth of Escherichia coli and Staphylococcus aureus in vitro. The present data support the identification of a novel antibacterial peptide, which was named Tostadin. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available